Next Article in Journal
A Norepinephrine Transporter Assay for the Screening of Natural Products
Previous Article in Journal
Screening of Chinese Medicinal Plants for Inhibition of COX-2 Gene Expression
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 7
10.3797/scipharm.oephg.21.PO-41
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays

by
N. FAKHRUDIN
*,
S. VOGL
,
P. PICKER
,
E. H. HEISS
,
J. SAUKEL
,
G. REZNICEK
,
B. KOPP
,
A. G. ATANASOV
and
V. M. DIRSCH
Department of Pharmacognosy, University of Vienna, Althanstraße 14, 1090, Vienna, Austria
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 240; https://doi.org/10.3797/scipharm.oephg.21.PO-41
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Peroxisome proliferator-activated receptors (PPARs) are transcription factors that belong to the nuclear receptor super family and represent promising therapeutic targets for several inflammatory and metabolic disorders. Nuclear factor-κB (NF-κB) is also a well-known transcription factor that regulates genes involved in inflammation.[...]

Share and Cite

MDPI and ACS Style

FAKHRUDIN, N.; VOGL, S.; PICKER, P.; HEISS, E.H.; SAUKEL, J.; REZNICEK, G.; KOPP, B.; ATANASOV, A.G.; DIRSCH, V.M. Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays. Sci. Pharm. 2009, 77, 240. https://doi.org/10.3797/scipharm.oephg.21.PO-41

AMA Style

FAKHRUDIN N, VOGL S, PICKER P, HEISS EH, SAUKEL J, REZNICEK G, KOPP B, ATANASOV AG, DIRSCH VM. Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays. Scientia Pharmaceutica. 2009; 77(Posters (PO)):240. https://doi.org/10.3797/scipharm.oephg.21.PO-41

Chicago/Turabian Style

FAKHRUDIN, N., S. VOGL, P. PICKER, E. H. HEISS, J. SAUKEL, G. REZNICEK, B. KOPP, A. G. ATANASOV, and V. M. DIRSCH. 2009. "Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays" Scientia Pharmaceutica 77, Posters (PO): 240. https://doi.org/10.3797/scipharm.oephg.21.PO-41

APA Style

FAKHRUDIN, N., VOGL, S., PICKER, P., HEISS, E. H., SAUKEL, J., REZNICEK, G., KOPP, B., ATANASOV, A. G., & DIRSCH, V. M. (2009). Screening for Discovery of Novel Peroxisome Proliferator-Activated Receptor-alpha and -gamma Agonists and Nuclear Factor-κB Inhibitors by Luciferase Reporter Gene Assays. Scientia Pharmaceutica, 77(Posters (PO)), 240. https://doi.org/10.3797/scipharm.oephg.21.PO-41

Article Metrics

Back to TopTop